Detalles de la búsqueda
1.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
N Engl J Med
; 388(3): 214-227, 2023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652353
2.
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.
J Infect Dis
; 229(2): 327-340, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466221
3.
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults.
Clin Infect Dis
; 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38537255
4.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37561027
5.
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults.
Clin Infect Dis
; 2023 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36610741
6.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036397
7.
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis.
Antimicrob Agents Chemother
; 67(1): e0131222, 2023 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36622154
8.
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.
J Antimicrob Chemother
; 78(6): 1460-1470, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071586
9.
Population Pharmacokinetic-Pharmacodynamic Model of Oxfendazole in Healthy Adults in a Multiple Ascending Dose and Food Effect Study and Target Attainment Analysis.
Antimicrob Agents Chemother
; 66(1): e0143221, 2022 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606333
10.
Population Pharmacokinetic Model of Oxfendazole and Metabolites in Healthy Adults following Single Ascending Doses.
Antimicrob Agents Chemother
; 65(4)2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33526484
11.
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.
Antimicrob Agents Chemother
; 64(11)2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816721
12.
Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial.
J Low Genit Tract Dis
; 24(3): 277-283, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32379102
13.
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30745383
14.
Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation.
Antimicrob Agents Chemother
; 62(9)2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941653
15.
Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.
Antimicrob Agents Chemother
; 62(9)2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941654
16.
A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
Transpl Infect Dis
; 20(3): e12874, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29512282
17.
Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.
J Infect Dis
; 214(7): 1020-9, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27443611
18.
Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1).
Emerg Infect Dis
; 22(7): 1253-6, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27315549
19.
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.
J Infect Dis
; 212(4): 552-61, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25649171
20.
Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.
J Infect Dis
; 212(4): 525-30, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25712967